NCT06340841 (LEMURSSI) is a Phase 1 clinical trial of Personal Incentives in Incentives, sponsored by University of Vermont.

Who is sponsoring NCT06340841?

NCT06340841 is sponsored by University of Vermont.

What drugs are being tested in NCT06340841?

Interventions in NCT06340841: Personal Incentives, Personal Restorative Incentives, Charity Incentives, Charity Restorative Incentives.

What condition does NCT06340841 study?

NCT06340841 studies Incentives.

Is NCT06340841 still recruiting?

NCT06340841 is currently recruiting now. Last updated 2 April 2024.

Last reviewed 2024-04-02 · How we verify

NCT06340841: LEMURSSI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LEMURS SSI: Evaluation of Behavioral Incentives

Recruiting now Phase 1 Last updated 2 April 2024

What this trial tests

Phase 1 trial testing Personal Incentives in Incentives in 200 participants. Currently enrolling.

Timeline

12 February 2024

Primary endpoint
31 May 2024

31 May 2028

Quick facts

Lead sponsor	University of Vermont
Phase	Phase 1
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	none
Primary purpose	health services research
Enrollment	200
Start date	12 February 2024
Primary completion	31 May 2024
Estimated completion	31 May 2028
Sites	1 location across United States

Drugs / interventions tested

Personal Incentives
Personal Restorative Incentives
Charity Incentives
Charity Restorative Incentives

Conditions studied

Incentives — all drugs for Incentives →

Sponsor

University of Vermont

Who can join

Adults 18 to 20, any sex, with Incentives. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this substudy is to determine if a brief single-session-intervention (SSI) coupled with different incentive strategies to support engaging in wellness-related activities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Incentives

Currently open trials in the same condition.

NCT06676787 — Evaluating the Impact of Demand-Side Incentives (DSI) on Zero Dose Burden and Immunisation Coverage in Nigeria · EARLY_PHASE1 · recruiting

Other University of Vermont trials

Trials by the same sponsor.

NCT07495098 — Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer · Phase 1 · not yet recruiting
NCT07440641 — RE-FIT (Remote Exercise for Physical Function in WTC Responders With Prostate Cancer) · NA · not yet recruiting
NCT06993129 — A Multi-Site Hybrid Type I Effectiveness-Implementation Randomized Trial of an Emergency Care Action Plan for Infants Wi · NA · not yet recruiting
NCT07383727 — Readiness to Change and the Implementation of Home Modifications for Adults Over 60 · NA · not yet recruiting
NCT06670079 — Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06340841 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Vermont
Last refreshed: 2 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06340841.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing